Advertisement

Psychoendocrinology of Depression

  • Gregory M. Brown
  • Paul Grof
  • Eva Grof

Abstract

Despite continuing progress in the treatment and prophylaxis of affective disorders, mental depression remains a major world health problem. Statistics on mental depression vary to some extent; however, they all attest to the high frequency of this disorder in the population. The lifetime risk of any one of us suffering from a depression of clinical severity has been estimated at between 10 and 15% (Weissman and Klerman, 1978). According to recent WHO reports, at least one hundred million people are suffering from mental depression of clinical intensity at any time (Sartorius, 1979).

Keywords

Depressed Patient Affective Disorder Biogenic Amine Growth Hormone Response Depressive Illness 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Altman, N., Sachar, E. J., Gruen, P. H., Halpern, F. S., and Eto, S., 1975, Reduced plasma LH concentration in post menopausal depressed women, Psychosom. Med. 37:274.PubMedGoogle Scholar
  2. Aprison, M. H., Takahashi, R., and Tachiki, K., 1978, Hypersensitive serotonergic receptors involved in clinical depression: A theory, in: Neuropharmacology and Behavior (B. Haber and M. H. Aprison, eds.), pp. 23–53, Plenum Press, New York.CrossRefGoogle Scholar
  3. Arana, G., Boyd, A. E., III, Reichlin, S., and Lipsitt, D., 1977, Prolactin levels in mild depression, Psychosom. Med. 39:193.PubMedGoogle Scholar
  4. Beskow, J., Gottfries, C. G., Roose, B. F., and Winblad, B., 1976, Determination of monoamines and monoamine metabolites in the human brain: Post mortem studies in a group of suicides and in a control group, Acta Psychiatr. Scand. 53:7.PubMedCrossRefGoogle Scholar
  5. Brambilla, F., Smeraldi, E., Sacchetti, E., Negri, F., Cocchi, D., and Muller, E. E., 1978, Deranged anterior pituitary responsiveness to hypothalamic hormones in depressed patients, Arch. Gen. Psychiatry 35:1231.PubMedCrossRefGoogle Scholar
  6. Brogden, R. N., Keel, R. C., Speight, T. M., and Avery, C. S., 1979, Mianserin: A review of its pharmacological properties and therapeutic efficacy in depressive illness, Drugs 16:273.CrossRefGoogle Scholar
  7. Brown, G. M., and Niles, L. P., 1981, Studies on melatonin and other pineal factors, in: Clinical Neuroendocrinology, Vol. 2 (G. M. Besser and L. Martini, eds.), pp. 205–264, Academic Press, New York.Google Scholar
  8. Brown, G. M., and Seggie, J. A., 1980, Neuroendocrine mechanisms and their implications for psychiatric research, in: Psychiatric Clinics of North America, Vol. 3, No. 2 (E. J. Sachar, ed.), pp. 205–221, Saunders, Philadelphia.Google Scholar
  9. Brown, G. M., Seeman, P., and Lee, T., 1976, Dopamine/neuroleptic receptors in basal hypothalamus pituitary, Endocrinology 99:1407.PubMedCrossRefGoogle Scholar
  10. Brown, G. M., Seggie, J. A., Chambers, J. W., and Ettigi, P. G., 1978, Psychoendocrinology and growth hormone: A review, Psychoneuroendocrinology 3:131.PubMedCrossRefGoogle Scholar
  11. Brown, G. M., Friend, W. C., and Chambers, J. W., 1979, Neuropharmacology of hypothalamic-pituitary regulation, in: Clinical Neuroendocrinology: A Pathophysiological Approach (G. Tolis, F. Labrie, J. B. Martin, and F. Naftolin, eds.), pp. 47–81, Raven Press, New York.Google Scholar
  12. Brown, W. A., and Shuey, I., 1980, Response to dexamethasone and subtype of depression, Arch. Gen. Psychiatry 37:747.PubMedCrossRefGoogle Scholar
  13. Bunney, W. E., Jr., and Gulley, B. L., 1978, The current status of research in the catecholamine theories of affective disorder, in: Biochemistry of Mental Disorders: New Vistas (E. Usdin and A. Mandell, eds.), pp. 83–100, Dekker, New York.Google Scholar
  14. Bunney, W. E., Jr., Pert, A., Rosenblatt, J., Pert, C. B., and Gallaper, D., 1979, Mode of action of lithium, Arch. Gen. Psychiatry 36:898.PubMedCrossRefGoogle Scholar
  15. Campbell, S., and Whitehead, M., 1977, Oestrogen therapy and the menopausal syndrome, Clin. Obstet. Gynecol. 4:31.Google Scholar
  16. Carroll, B. J., 1976, Psychoendocrine relationships in affective disorders, in: Modern Trends in Psychosomatic Medicine, Vol. 3 (O. W. Hill, ed.), pp. 121–153, Butterworths, London.Google Scholar
  17. Carroll, B. J., Curtis, G. C., and Mendels, J., 1976a, Neuroendocrine regulation in depression. I. Limbic system-adrenocortical dysfunction, Arch. Gen. Psychiatry 33:1039.PubMedCrossRefGoogle Scholar
  18. Carroll, B. J., Curtis, G. C., and Mendels, J., 1976b, Neuroendocrine regulation in depression. II. Discrimination of depressed from nondepressed patients, Arch. Gen. Psychiatry 33:1051.PubMedCrossRefGoogle Scholar
  19. Checkley, S. A., 1979, Corticosteroid and growth hormone responses to methylamphetamine in depressive illness, Psychol. Med. 9:107.PubMedCrossRefGoogle Scholar
  20. Cuenca, E., Galiana, J., and Canete, J. M., 1978, Prolactin in depression, Arch. Farmacol. Toxicol. 4:41.Google Scholar
  21. Ehrensing, R. H., Kastin, A. J., Schalch, D. S., Friesen, H. G., Vargas, J. R., and Schally, A. V., 1974, Affective state and thyrotropin and prolactin responses after repeated injections of thyrotropin-releasing hormone in depressed patients, Am. J. Psychiatry 131:714.PubMedGoogle Scholar
  22. Ettigi, P. G., and Brown, G. M., 1977, Psychoneuroendocrinology of affective disorder: An overview, Am. J. Psychiatry 134:493.PubMedGoogle Scholar
  23. Ettigi, P. G., and Brown, G. M., 1979, Psychoendocrine correlates in affective disorder, in: Neuroendocrine Correlates in Neurology and Psychiatry (E. E. Müller and A. Agnoli, eds.), pp. 225–238, Elsevier/North-Holland, Amsterdam.Google Scholar
  24. Ettigi, P. G., Brown, G. M., and Seggie, J. A., 1979, TSH and LH responses in subtypes of depression, Psychosom. Med. 41:203.PubMedGoogle Scholar
  25. Frohman, L. A., and Stachura, M. E., 1975, Neuropharmacologic control of neuroendocrine function in man, Metabolism 24:211.PubMedCrossRefGoogle Scholar
  26. Furlong, F. W., Brown, G. M., and Beeching, M. F., 1976, Thyrotropin-releasing hormone: Differential antidepressant and endocrinological effects, Am. J. Psychiatry 133:1187.PubMedGoogle Scholar
  27. Garfinkel, P. E., Brown, G. M., Warsh, J. J., and Stancer, H. C., 1979, Neuroendocrine responses to carbidopa in primary affective disorders, Psychoneuroendocrinology 4:13.PubMedCrossRefGoogle Scholar
  28. Garver, D. L., Pandey, G. N., Dekirmenjian, H., and Deleon-Jones, F., 1975, Growth hormone and catecholamines in affective disease, Am. J. Psychiatry 132:1149.PubMedGoogle Scholar
  29. Gold, M. S., Pottash, A. L., Ryan, N., Sweeny, D. R., Davies, R. K., and Martin, D. M., 1980, TRH-induced TSH response in unipolar, bipolar and secondary depressions: Possible utility in clinical assessment and differential diagnosis, Psychoneuroendocrinology 5:147.PubMedCrossRefGoogle Scholar
  30. Gold, P. W., and Goodwin, F. K., 1978, Vasopressin in affective illness, Lancet I:1233.CrossRefGoogle Scholar
  31. Gold, P. W., Weingartner, H., Ballenger, J. C., Goodwin, F. K., and Post, R. M., 1979, Effects of 1-desamino-8-D-arginine vasopressin on behaviour and cognition in primary affective disorder, Lancet II:992.CrossRefGoogle Scholar
  32. Goldzieher, J. W., Dozier, T. S., and Smith, K. D., 1976, Improving the diagnostic reliability of rapidly fluctuating plasma hormone levels by optimized multiple-sampling techniques, J. Clin. Endocrinol. Metab. 43:824.PubMedCrossRefGoogle Scholar
  33. Gregoire, F., Brauman, H., De Buck, R., and Corvilain, J., 1977, Hormone release in depressed patients before and after recovery, Psychoneuroendocrinology 2:303.PubMedCrossRefGoogle Scholar
  34. Gruen, P. H., Sachar, E. J., Altman, N., and Sassin, J., 1975, Growth hormone responses to hypoglycemia in post-menopausal depressed women, Arch. Gen. Psychiatry 32:31.PubMedCrossRefGoogle Scholar
  35. Halbreich, U., Assad, M., and Ben-David, M., 1978, Prolactin secretion during and after noveril infusions to depressive patients, Psychopharmacologia 56:167.CrossRefGoogle Scholar
  36. Halbreich, U., Grunhaus, L., and Ben-David, M., 1979, Twenty-four-hour rhythm of prolactin in depressive patients, Arch. Gen. Psychiatry 36:1183.PubMedCrossRefGoogle Scholar
  37. Hendler, N. H., 1978, Lithium pharmacology and physiology, in: Handbook of Pharmacology, Vol. 14, Affective Disorders: Drug Actions in Animals and Man (L. L. Iversen, S. D. Iversen, and S. H. Snyder, eds.), pp. 233–273, Plenum Press, New York.Google Scholar
  38. Herrmann, W. M., and Beach, R. C., 1978, The psychotropic properties of estrogens, Pharmak-opsychiatr. Neuro-psychopharmakol. 11:164.Google Scholar
  39. Janowsky, D. S., Leichner, P., Parker, D., Judd, L., Huey, L., and Clopton, P., 1978, Methylphenidate and serum prolactin in man, Psychopharmacologia 58:43.CrossRefGoogle Scholar
  40. Kirkegaard, C., Bjorum, N., Cohn, D., and Lauridsen, V. B., 1978, Thyrotrophin-releasing hormone (TRH) stimulation test in manic-depressive illness, Arch. Gen. Psychiatry 35:1017.PubMedCrossRefGoogle Scholar
  41. Laakmann, G., and Benkert, O., 1978, Neuroendokrinologie und Psychopharmaka, Arnzeim. Forsch. 28:1277.Google Scholar
  42. Ladisich, W., 1977, Influence of progesterone on serotonin metabolism: A possible causal factor for mood changes, Psychoneuroendocrinology 2:257.PubMedCrossRefGoogle Scholar
  43. Lal, S., Nair, N. P. V., and Guyda, H., 1978, Effect of lithium on hypothalamic-pituitary dopaminergic function, Acta Psychiatr. Scand. 57:91.PubMedCrossRefGoogle Scholar
  44. Lewy, A. J., Wehr, J. A., Gold, P., and Goodwin, F. K., 1979, Plasma melatonin in manic-depressive illness, in: Catecholamines: Basic and Clinical Frontiers, Vol. 2 (E. Usdin, I. J. Kopin, and T. Barchas, eds.), pp. 1173–1175, Pergamon Press, Elmsford, N. Y.Google Scholar
  45. Linnoila, M., Lamberg, B. A., Rosberg, G., Karonen, S. L., and Welin, M. G., 1979, Thyroid hormones and TSH, prolactin and LH responses to repeated TRH and LRH injections in depressed patients, Acta Psychiatr. Scand. 59:536.PubMedCrossRefGoogle Scholar
  46. Lloyd, K. G., Farley, I. J., Deck, J. H., and Hornykiewicz, O., 1974, Serotonin and 5-hydrox-yindoleacetic acid in discrete areas of the brainstem of suicide victims and control patients, Adv. Biochem. Psychopharmacol. 11:387.PubMedGoogle Scholar
  47. Maas, J. W., 1979, Biochemistry of the affective disorders, Hosp. Pract. 14:113.PubMedGoogle Scholar
  48. Maas, J. W., Dekirmenjian, H., and Fawcett, J. A., 1974, MHPG excretion by patients with affective disorders, Int. Pharmacopsychiatry 9:14.PubMedGoogle Scholar
  49. Maeda, K., Kato, Y., Ohgo, S., Chihara, K., Yoshimoto, Y., Yamaguchi, N., Muromaru, S., and Imura, H., 1975, Growth hormone and prolactin release after injection of thyrotropin-releasing hormone in patients with depression, J. Clin. Endocrinol. Metab. 40:501.PubMedCrossRefGoogle Scholar
  50. Mandell, A. J., and Knapp, S., 1979, Asymmetry and mood, emergent properties of serotonin regulation, Arch. Gen. Psychiatry 36:909.PubMedCrossRefGoogle Scholar
  51. Martin, J. B., Reichlin, S., and Brown, G. M., 1977, Clinical Neuroendocrinology, pp. 1–410, Davis, Philadelphia.Google Scholar
  52. Matussek, N., 1978, Effect of amphetamine and Clonidine on human growth hormone release in psychiatric patients and controls, in: Depressive Disorders (S. Garattini, ed.), pp. 431–46., Schattauer Verlag, Stuttgart.Google Scholar
  53. Mendels, J., 1974, Amine depletion as an experimental approach to the aminergic hypothesis, Psychopharmacol. Bull. 10:54.PubMedGoogle Scholar
  54. Mendelwicz, J., Linkowski, P., Branchey, L., Weinberg, U., Weitzman, E. D., and Branchey, M., 1979, Abnormal 24 hour pattern of melatonin secretion in depression, Lancet 11:1362.CrossRefGoogle Scholar
  55. Nielsen, J. L., 1980, Plasma prolactin during treatment with nortriptyline, Neuropsychobiology 6:52.PubMedCrossRefGoogle Scholar
  56. Nuller, J. L., and Ostroumova, M. N., 1980, Resistance to inhibiting effect of dexamethasone in patients with endogenous depression, Acta Psychiatr. Scand. 61:169.PubMedCrossRefGoogle Scholar
  57. O’Dea, J. P. K., Gould, D., Hallberg, M., and Wieland, R. G., 1978, Prolactin changes during electroconvulsive therapy, Am. J. Psychiatr. 135:609.PubMedGoogle Scholar
  58. Orth, J. P., Braccini, T., Krebs, B. P., and Darcourt, G., 1979, The psychotropic action of TRH, Encephale 5:375.PubMedGoogle Scholar
  59. Rubin, R. T., and Kendler, K. S., 1977, Psychoneuroendocrinology: Fundamental concepts and correlates in depression, in: Depression: Clinical, Biological and Psychological Perspectives (E. Usdin, ed.), pp. 122–138., Brunner/Mazel, New York.Google Scholar
  60. Sachar, E. J., 1967, Corticosteroids in depressive illness. I. A reevaluation of control issues and the literature, Arch. Gen. Psychiatry 17:544.CrossRefGoogle Scholar
  61. Sachar, E. J., 1975, Hormonal changes in stress and mental illness, Hosp. Pract. 10:(7):49.Google Scholar
  62. Sachar, E. J., Hellman, L., Roffwarg, H. P., Halpern, F. S., Fukushima, D. K., and Gallagher, T. F., 1973, Disrupted 24-hour patterns of Cortisol secretion in psychotic depression, Arch. Gen. Psychiatry 28:19.PubMedCrossRefGoogle Scholar
  63. Sachar, E. J., Altman, N., Gruen, P. H., Glassman, A., Halpern, F. S., and Sassin, J., 1975, Human growth hormone response to levodopa: Relation to menopause, depression and plasma dopa concentration, Arch. Gen. Psychiatry 32:502.PubMedCrossRefGoogle Scholar
  64. Sachar, E. J., Asnis, G., Halbreich, U., Nathan, R. S., and Halpern, F., 1980, Recent studies in the neuroendocrinology of major depressive disorders, in: Psychiatric Clinics of North America, Vol. 3, No. 2 (E. J. Sachar, ed.), pp. 313–326, Saunders, Philadelphia.Google Scholar
  65. Sack, R. L., and Goodwin, F. K., 1974, Inhibition of dopamine β-hydroxylase in manic patients, Arch. Gen. Psychiatry 31:649.PubMedCrossRefGoogle Scholar
  66. Sartorius, N., 1979, Depressive disorders, a major public health problem, in: Mood Disorders (F. J. Ayd and J. J. Taylor, eds.), pp. 1–8, Ayd Medical Communications, Baltimore.Google Scholar
  67. Schildkraut, J. J., 1965, The catecholamine hypothesis of affective disorders: A review of supporting evidence, Am. J. Psychiatry 122:509.PubMedGoogle Scholar
  68. Schildkraut, J. J., 1973, Pharmacology—The effects of lithium on biogenic amines, in: Lithium: Its Role in Psychiatric Research and Treatment (S. Gershon and B. Shopsin, eds.), pp. 51–73, Plenum Press, New York.Google Scholar
  69. Schildkraut, J. J., 1974, Biogenic amines and affective disorders, Annu. Rev. Med. 25:333.PubMedCrossRefGoogle Scholar
  70. Schlesser, M. A., Winokur, G., and Sherman, B. M., 1980, Hypothalamic-pituitary-adrenal axis activity in depressive illness, Arch. Gen. Psychiatry 37:737.PubMedCrossRefGoogle Scholar
  71. Schneider, M. A., Brotherton, P. L., and Hailes, J., 1977, The effect of exogenous oestrogens on depression in menopausal women, Med. J. Aust. 2:162.PubMedGoogle Scholar
  72. Shopsin, B., and Gershon, S., 1971, Plasma Cortisol response to dexamethasone suppression in depressed and control patients, Arch. Gen. Psychiatry 24:320.PubMedCrossRefGoogle Scholar
  73. Shopsin, B., and Gershon, S., 1978, Lithium: Clinical considerations, in: Handbook of Psychopharmacology, Vol. 14, Affective Disorders: Drug Actions in Animals and Man (L. L. Iversen, S. D. Iversen, and S. H. Snyder, eds.), pp. 275–325, Plenum Press, New York.Google Scholar
  74. Sourkes, T. L., 1977, Biochemistry of mental depression, Can. Psychiatr. Assoc. J. 22:487.Google Scholar
  75. Stancer, H. C., Quarrington, B., Cookson, B. A., Brown, G. M., Bonkalo, A., and Lyall, W. A. L., 1969, A longitudinal drug study and central amines, Arch. Gen. Psychiatry 20:290.PubMedCrossRefGoogle Scholar
  76. Stokes, P. E., Stoll, P. M., Mattson, M. R., and Sollod, R. N., 1976, Diagnosis and psychopathology in psychiatric patients resistant to dexamethasone, in: Hormones, Behavior and Psychopathology (E. J. Sachar, ed.), pp. 225–229, Raven Press, New York.Google Scholar
  77. Sulser, F., 1978, Functional aspects of the norepinephrine receptor coupled adenylate cyclase system in the limbic forebrain and its modification by drugs which precipitate or alleviate depression: Molecular approaches to an understanding of affective disorders, Pharmakopsychiatr. Neuro-Psychopharmakol. 11:43.Google Scholar
  78. Sulser, F., 1979, Tricyclic antidepressants: Animal pharmacology (biochemical and metabolic aspects), in: Handbook of Psychopharmacology, Vol. 14 Affective Disorders: Drug Actions in Animals and Man (L. L. Iversen, S. D. Iversen, and S. H. Snyder, eds.), pp. 157–197, Plenum Press, New York.Google Scholar
  79. Takahashi, S., Kondo, H., Yoshimura, M., and Ochi, Y., 1974, Growth hormone responses to administration of L-5-hydroxytryptophan (l-5-HTP) in manic-depressive psychosis, in: Psychoneuroendocrinology: Proceedings (N. Hatotani, ed.), pp. 32–38, Karger, Basel.Google Scholar
  80. Taracha, E., Szukalski, B., and Zaluska, M., 1978, Plasma Cortisol level in patients with affective disturbances and its correlation with tryptophan and 5-hydroxyindoleacetic acid [Preliminary communication], Psychiatr. Pol. 12:317.PubMedGoogle Scholar
  81. van Praag, H. M., 1977, Indoleamines in depression, in: Neuroregulators and Psychiatric Disorders (E. Usdin, D. A. Hamburg, and J. D. Barchas, eds.), pp. 163–176, Oxford University Press, London.Google Scholar
  82. Weeke, A., and Weeke, J., 1978, Disturbed circadian variation of serum thyrotropin in patients with endogenous depression, Acta Psychiatr. Scand. 57:281.PubMedCrossRefGoogle Scholar
  83. Weissman, M. M., and Klerman, G. L., 1978, Epidemiology of mental disorders, Arch. Gen. Psychiatry 35:705.PubMedCrossRefGoogle Scholar
  84. Wetterberg, L., Beck-Friis, J., Aperia, B., and Petterson, U., 1979, Melatonin/cortisol ratio in depression, Lancet II:1361.CrossRefGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1984

Authors and Affiliations

  • Gregory M. Brown
    • 1
  • Paul Grof
    • 2
  • Eva Grof
    • 3
  1. 1.Department of NeurosciencesMcMaster UniversityHamiltonCanada
  2. 2.Department of PsychiatryMcMaster University, and Hamilton Psychiatric HospitalHamiltonCanada
  3. 3.Department of PsychiatryMcMaster UniversityHamiltonCanada

Personalised recommendations